Efficacy of intravitreal Aflibercept in patients with neovascular AMD who were previously treated with Ranibizumab based on a Treat and Extend protocol

被引：0
|
作者：
Turksever, C.
Prunte, C.
Hatz, K.
机构：
来源：
ACTA OPHTHALMOLOGICA | 2015年 / 93卷
关键词：
D O I：
10.1111/j.1755-3768.2015.0396
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
ABS15-0396
引用
收藏
页数：3
相关论文
共 50 条
  • [41] EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB IN ASIAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Subgroup Analyses From the VIEW Trials
    Wong, Tien Yin
    Cheung, Chui Ming Gemmy
    Lai, Timothy Y. Y.
    Chen, Shih-Jen
    Lee, Won Ki
    Yoon, Young Hee
    Iida, Tomohiro
    Tueckmantel, Claudia
    Sowade, Olaf
    Ogura, Yuichiro
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (03): : 537 - 547
  • [42] Efficacy outcomes and treatment burden of 'as required' ranibizumab to 'Treat and Extend' aflibercept for neovascular Age - related Macular Degeneration: 12 month pre and post switch analysis in clinical practice
    Airody, Archana
    Mankowska, Aleksandra
    Topping, Nicola
    Hanson, Richard
    Walters, Gavin
    Bailey, Fiona
    Gale, Richard
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [43] Efficacy of Intravitreal Aflibercept Administered using Treat-and-Extend Regimen over 2 Years in Patients with Neovascular Age-Related Macular Degeneration: 1 Year ARIES Results.
    Mitchell, Paul
    Souied, Eric H.
    Midena, Edoardo
    Holz, Frank G.
    Hykin, Philip G.
    Wolf, Sebastian
    Allmeier, Helmut
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [44] Four-year outcomes of intravitreal aflibercept treatment for neovascular age-related macular degeneration using a treat-and-extend regimen in Japanese patients
    Ishibashi, Koki
    Haruta, Masatoshi
    Ishibashi, Yumi
    Noda, Rie
    Dake, Shotaro
    Yoshida, Shigeo
    THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2021, 13
  • [45] Comparison of Long-term Efficacy of Intravitreal Ranibizumab in Diabetic Retinopathy following Monthly vs Pro Re Nata vs Treat and Extend Protocol
    Sarkar, Avik Dey
    Thakur, Sanjay Kumar Daulat
    Roy, Rupam
    Sarkar, Ajoy Dey
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (04) : NC09 - NC12
  • [46] Efficacy of aflibercept in the second eyes of neovascular age-related macular degeneration patients who refractory to bevacizumab or ranibizumab in the first eyes
    Ma, Dae Joong
    Park, Un-Chul
    Yu, Hyeong Gon
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [47] Evaluation of the efficiency of intravitreal Aflibercept in patients affected with Occult Choroidal Neovascularisation (OCNV), Polypoidal Choroidal Vasculopathy (IPVC) and Retinal Angiomatous Proliferation (RAP) previously treated with intravitreal Ranibizumab
    Altimari, Simona
    Salvati, Roberta
    Zompatori, Luigi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [48] Prospective noninterventional BLUE SKY study evaluating the efficacy of brolucizumab in treatment-naive and previously treated patients with neovascular AMD
    Faatz, H.
    Feltgen, N.
    Gutfleisch, M.
    Heimes-Bussmann, B.
    Krohne, T. U.
    Liakopoulos, S.
    Liegl, R.
    Lommatzsch, A.
    Mussinghoff, P.
    Rehak, M.
    Schmitz-Valckenberg, S.
    Spital, G.
    Stanzel, B.
    Ziemssen, F.
    Haegele, B.
    Junkes, C.
    Porstner, M.
    Voegeler, J.
    Gmeiner, B.
    Pauleikhoff, D.
    OPHTHALMOLOGIE, 2023, 120 (03): : 294 - 300
  • [49] DEVELOPMENT OF MACULAR ATROPHY IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) TREATED WITH RANIBIZUMAB OR AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN: PRIMARY RESULTS FROM THE RIVAL STUDY, A RANDOMIZED CLINICAL TRIAL
    Gillies, Mark C.
    Hunyor, Alex P.
    Arnold, Jennifer J.
    Pecheur, Francois L.
    Heath, Ronelle-Mare
    Guymer, Robyn H.
    McAllister, Ian L.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 46 : 118 - 118
  • [50] Intravitreal Aflibercept in a Routine Treat and Extend (T&E) Regimen for Treatment-Naive wet AMD Patients: 2-Year Outcomes of the observational ASTERIA Study
    Ebneter, Andreas
    Michels, Stephan
    Imesch, Pascal
    Eilenberger, Felix
    Oesch, Susanne
    Pruente, Christian
    Hatz, Katja
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
12345